4559
Zeria Pharmaceutical Co., Ltd.
2026/02/05
Consolidated net sales for the third quarter of fiscal year ending March 2026 were JPY 64,077 million (down 1.1% YoY), operating income was JPY 8,566 million (down 16.4% YoY), and net income attributable to owners of parent for the quarter was JPY 5,554 million (down 32.5% YoY).
